MYX.AX
Mayne Pharma Group Ltd
Price:  
2.46 
AUD
Volume:  
340,168.00
Australia | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MYX.AX Stock Forecast & Price Target

MYX.AX Stock Price Forecast

The average stock forecast for Mayne Pharma Group Ltd (MYX.AX) in the next 12 months is 6.22 AUD. This price target corresponds to an upside of 170.52%. The range of stock forecasts for MYX.AX is 6.16 - 6.41 AUD. Based on the ratings of 5 analysts, the consensus recommendation for MYX.AX is BUY.
Target Low Average Median High
Price (AUD) 6.16 6.22 6.22 6.41
Upside 167.87% 170.52% 170.52% 178.48%

Recommendation Trends

The latest consensus rating for MYX.AX is "BUY". This is the average recommendation of 5 analysts: 0 strong sell, 0 sell, 1 hold, 3 buy, 1 strong buy. In the previous period, 5 analysts also majorly recommmended "BUY" for MYX.AX.

MYX.AX Financial Stock Forecast

Revenue This Year
438.79M
6.24%
from 413.01M
Revenue Next Year
523.48M
19.30%
from 438.79M
EPS This Year
-0.03
-97.09%
from -1.15
EPS Next Year
0.13
-472.73%
from -0.03